Literature DB >> 21440052

Features of sepsis caused by pulmonary infection with Francisella tularensis Type A strain.

Jyotika Sharma1, Chris A Mares, Qun Li, Elizabeth G Morris, Judy M Teale.   

Abstract

The virulence mechanisms of Francisella tularensis, the causative agent of severe pneumonia in humans and a CDC category A bioterrorism agent, are not fully defined. As sepsis is the leading cause of mortality associated with respiratory infections, we determined whether, in the absence of any known bacterial toxins, a deregulated host response resulting in sepsis syndrome is associated with lethality of respiratory infection with the virulent human Type A strain SchuS4 of F. tularensis. The C57BL/6 mice infected intranasally with a lethal dose of SchuS4 exhibited high bacterial burden in systemic organs and blood indicative of bacteremia. In correlation, infected mice displayed severe tissue pathology and associated cell death in lungs, liver and spleen. Consistent with our studies with murine model strain Francisella novicida, infection with SchuS4 caused an initial delay in upregulation of inflammatory mediators followed by development of severe sepsis characterized by exaggerated cytokine release, upregulation of cardiovascular injury markers and sepsis mediator alarmins S100A9 and HMGB1. This study shows that pulmonary tularemia caused by the Type A strain of F. tularensis results in a deregulated host response leading to severe sepsis and likely represents the major cause of mortality associated with this virulent pathogen.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21440052      PMCID: PMC3090489          DOI: 10.1016/j.micpath.2011.03.007

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  50 in total

Review 1.  Stress molecules in sepsis and systemic inflammatory response syndrome.

Authors:  Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  FEBS Lett       Date:  2007-04-04       Impact factor: 4.124

Review 2.  Harmful molecular mechanisms in sepsis.

Authors:  Daniel Rittirsch; Michael A Flierl; Peter A Ward
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

3.  Expression and contribution of endogenous IL-13 in an experimental model of sepsis.

Authors:  A Matsukawa; C M Hogaboam; N W Lukacs; P M Lincoln; H L Evanoff; R M Strieter; S L Kunkel
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

Review 4.  Severe sepsis and septic shock: the role of gram-negative bacteremia.

Authors:  Robert S Munford
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

Review 5.  Inflammatory markers in SIRS, sepsis and septic shock.

Authors:  I Herzum; H Renz
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

6.  Initial delay in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns.

Authors:  Chris A Mares; Sandra S Ojeda; Elizabeth G Morris; Qun Li; Judy M Teale
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

7.  Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensis.

Authors:  J Wayne Conlan; Xigeng Zhao; Gregory Harris; Hua Shen; Mark Bolanowski; Cecilia Rietz; Anders Sjostedt; Wangxue Chen
Journal:  Mol Immunol       Date:  2008-03-05       Impact factor: 4.407

Review 8.  The immunology of sepsis.

Authors:  S Sriskandan; D M Altmann
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

9.  Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis.

Authors:  Philipp Schuetz; Mirjam Christ-Crain; Nils G Morgenthaler; Joachim Struck; Andreas Bergmann; Beat Müller
Journal:  Endothelium       Date:  2007 Nov-Dec

Review 10.  Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis.

Authors:  Christian Bopp; Angelika Bierhaus; Stefan Hofer; Axel Bouchon; Peter P Nawroth; Eike Martin; Markus A Weigand
Journal:  Crit Care       Date:  2008-01-09       Impact factor: 9.097

View more
  39 in total

1.  Proteomic analysis of bronchoalveolar lavage fluid proteins from mice infected with Francisella tularensis ssp. novicida.

Authors:  Susan M Varnum; Bobbie-Jo M Webb-Robertson; Joel G Pounds; Ronald J Moore; Richard D Smith; Charles W Frevert; Shawn J Skerrett; David Wunschel
Journal:  J Proteome Res       Date:  2012-06-22       Impact factor: 4.466

2.  Detrimental Influence of Alveolar Macrophages on Protective Humoral Immunity during Francisella tularensis SchuS4 Pulmonary Infection.

Authors:  Donald J Steiner; Yoichi Furuya; Dennis W Metzger
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

3.  Lipoxin A4, a 5-lipoxygenase pathway metabolite, modulates immune response during acute respiratory tularemia.

Authors:  Anju Singh; Tabassum Rahman; Rose Bartiss; Alireza Arabshahi; Jeevan Prasain; Stephen Barnes; Florin Marcel Musteata; Timothy J Sellati
Journal:  J Leukoc Biol       Date:  2016-09-14       Impact factor: 4.962

4.  Hematopoietic MyD88 and IL-18 are essential for IFN-γ-dependent restriction of type A Francisella tularensis infection.

Authors:  Jerod A Skyberg; Carolyn A Lacey
Journal:  J Leukoc Biol       Date:  2017-09-26       Impact factor: 4.962

5.  Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia.

Authors:  Sivakumar Periasamy; Anju Singh; Bikash Sahay; Tabassum Rahman; Paul J Feustel; Giang H Pham; Edmund J Gosselin; Timothy J Sellati
Journal:  J Leukoc Biol       Date:  2011-07-01       Impact factor: 4.962

Review 6.  Targeting the "cytokine storm" for therapeutic benefit.

Authors:  Riccardo V D'Elia; Kate Harrison; Petra C Oyston; Roman A Lukaszewski; Graeme C Clark
Journal:  Clin Vaccine Immunol       Date:  2013-01-02

7.  Contributions of TolC Orthologs to Francisella tularensis Schu S4 Multidrug Resistance, Modulation of Host Cell Responses, and Virulence.

Authors:  Erik J Kopping; Christopher R Doyle; Vinaya Sampath; David G Thanassi
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

8.  Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection.

Authors:  Sherry L Kurtz; Oded Foreman; Catharine M Bosio; Miriam R Anver; Karen L Elkins
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

9.  Role of NK cells in host defense against pulmonary type A Francisella tularensis infection.

Authors:  Deanna M Schmitt; Dawn M O'Dee; Matthew J Brown; Joseph Horzempa; Brian C Russo; Penelope A Morel; Gerard J Nau
Journal:  Microbes Infect       Date:  2012-12-01       Impact factor: 2.700

10.  Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac mice.

Authors:  Raju Sunagar; Sudeep Kumar; Brian J Franz; Edmund J Gosselin
Journal:  Vaccine       Date:  2016-05-13       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.